| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.065 | 0.3 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |